Apidra SoloStar (stylo prérempli), solution injectable

7680580560014 CH-58056 Injektionslösung
Apidra SoloStar (stylo prérempli), solution injectable
Apidra SoloStar (stylo prérempli), solution injectable
Apidra SoloStar (stylo prérempli), solution injectable
1 / 3
google

Article details

Package size
5 x 3
Selling units
5
Measure
ml
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
04/06/2024
Patient information leaflet
Français
04/06/2024
Patient information leaflet
Italien
04/06/2024

Detailed composition

Substance Quantity Type Category
(N/A)
3.49 MG Substance Wirkstoff (Principe actif)
(N/A)
100.0 U Substance WIIS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
(N/A)
3.15 MG Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK
natrium
1.97 MG Substance HBESI

Reimbursement information

Public price
CHF 50.90
Specialties list
Yes
Generic
No
SL addition date: 01/02/2008

Authorization holder

Sanofi-Aventis (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
58056
Drug name
Apidra SoloStar (stylo prérempli), solution injectable
Galenic form
LSPA
ATC Code
A10AB06
Authorization status
Z
Dispensing category
B
First authorization
10/08/2007
Authorization expiration date
31/12/9999
IT Number
07.06.1.
Domain
Human medicine
Field of application
Diabetes mellitus bei Erwachsenen

Package details

Description (FR)
APIDRA SoloStar sol inj 5 stylo pré 3 ml
Description (DE)
APIDRA SoloStar Inj Lös 5 Fertpen 3 ml
Market launch
10/08/2007
Narcotic (BTM)
No

Other package sizes (1)

None
1 x 3 ML
GTIN: None
Not in V1